[Code of Federal Regulations] [Title 10, Volume 1] [Revised as of January 1, 2004] From the U.S. Government Printing Office via GPO Access [CITE: 10CFR26.71] [Page 447-448] TITLE 10--ENERGY CHAPTER I--NUCLEAR REGULATORY COMMISSION PART 26--FITNESS FOR DUTY PROGRAMS--Table of Contents Sec. 26.71 Recordkeeping requirements. Each licensee subject to this part and each contractor and vendor implementing a licensee approved program under the provisions of Sec. 26.23 shall-- (a) Retain records of inquiries conducted in accordance with Sec. 26.27(a), [[Page 448]] that result in the granting of unescorted access to protected areas, until five years following termination of such access authorizations; (b) Retain records of confirmed positive test results which are concurred in by the Medical Review Officer, and the related personnel actions for a period of at least five years; (c) Retain records of persons made ineligible for three years or longer for assignment to activities within the scope of this part under the provisions of Sec. 26.27(b) (2), (3), (4) or (c), until the Commission terminates each license under which the records were created; and (d) Collect and compile fitness-for-duty program performance data on a standard form and submit this data to the Commission within 60 days of the end of each 6-month reporting period (January-June and July- December). The data for each site (corporate and other support staff locations may be separately consolidated) must include: random testing rate; drugs tested for and cut-off levels, including results of tests using lower cut-off levels and tests for other drugs; workforce populations tested; numbers of tests and results by population, and type of test (i.e., pre-access, random, for-cause, etc.); substances identified; summary of management actions; and a list of events reported. The data must be analyzed and appropriate actions taken to correct program weaknesses. The data and analysis must be retained for three years. Any licensee choosing to temporarily suspend individuals under the provisions of Sec. 26.24(d) must report test results by process stage (i.e., onsite screening, laboratory screening, confirmatory tests, and MRO determinations) and the number of temporary suspensions or other administrative actions taken against individuals based on onsite unconfirmed screening positives for marijuana (THC) and for cocaine. [54 FR 24494, June 7, 1989, as amended at 57 FR 55444, Nov. 25, 1992]